Evidence 1
Activity
Activity
<5% Hemolysis
Toxicity
256 µg/mL
Hemolytic
Cytotoxic
<5% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Structure-based design of an indolicidin peptide analogue with increased protease stability. | Biochemistry | 2003